Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for general anesthesia during transurethral resection of the prostate in elderly patients
ChiCTR2000040081Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of remimazolam in prostate disease (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Incidence of postoperative delirium (POD). Planned start Dec 2020; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
prostate disease
Beyond the preview
Go deeper on ChiCTR2000040081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040081.